We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4204:TSESekisui Chemical Co., Ltd. Analysis

Data as of 2026-06-21 - not real-time

¥2,471.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Sekisui Chemical (4204.T) is trading at ¥2,471, notably above its DCF‑derived fair value of roughly ¥1,830, suggesting the market is pricing in a premium. The stock’s PE ratio of 13.5 is well below the industry average of 31.4, while the dividend yield of 3.32% and a payout ratio under 45% underscore attractive income potential. Technically, the price sits above the 20‑day SMA (¥2,367) and 50‑day SMA (¥2,424) but remains under the 200‑day SMA (¥2,671), indicating short‑term momentum amid a longer‑term bearish bias. The RSI at 60.8 and a bullish MACD histogram (+22.8) provide some upside momentum, yet decreasing volume and a bearish trend direction flag caution.
Fundamentally, revenue growth is modest at 2% and margins are moderate (gross 32%, operating 9.6%). Strong cash generation (operating cash flow ¥78.3 bn) supports the dividend, though free cash flow is negative. The company’s low beta (0.26) points to limited market volatility, but a 30‑day volatility of 21.7% and a max drawdown near 26% highlight price swings. Diversified exposure across chemicals, plastics, medical and renewable‑energy segments mitigates sector‑specific risks, while the “Extreme Greed” sentiment index (91.46) suggests heightened market optimism.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish longer‑term trend (price below 200‑day SMA)
  • Decreasing volume and high recent volatility
  • Bullish MACD histogram offering limited upside

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Attractive dividend yield with sustainable payout
  • Valuation premium relative to DCF fair value
  • Modest revenue growth and stable operating margins

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Diversified product portfolio across chemicals, medical and renewable sectors
  • Low beta indicating defensive characteristics
  • Potential upside from perovskite solar and infrastructure renovation businesses

Key Metrics & Analysis

Financial Health

Revenue Growth2.00%
Profit Margin5.74%
P/E Ratio13.5
ROE9.01%
ROA4.82%
Debt/Equity16.43
P/B Ratio1.2
Op. Cash Flow¥78.3B
Free Cash Flow¥-33401499648
Industry P/E31.4

Technical Analysis

TrendBearish
RSI60.8
Support¥2,248.00
Resistance¥2,511.00
MA 20¥2,367.28
MA 50¥2,424.05
MA 200¥2,670.55
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

Fair Value¥1,830.65
Target Price¥2,606.00
Upside/Downside5.46%
GradeOvervalued
TypeValue
Dividend Yield3.32%

Risk Assessment

Beta0.27
Volatility21.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.